NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.
Read Original Story

New Stomach Stapling Procedure: No Surgery, Less Recovery Time

Rating

3 Star

New Stomach Stapling Procedure: No Surgery, Less Recovery Time

Our Review Summary

This extremely brief television news segment about a non-surgical treatment for morbid obesity manages to describe the procedure, contrast it with conventional treatment, and indicate that it is being studied and not yet available.

Yet as the ratings here show, both the brevity of the story and the way the time is used leave the story short of journalistic best practices. 

At the very least, the report should have:

  • included an interview with a dispassionate observer
  • mentioned the possible harms and shortcomings of the procedure
  • stated more plainly that the procedure may never be approved in the U.S., and 
  • disclosed that the owner of the procedure’s patent is funding the research

Ideally it also would have explained a bit more about the findings so far–which patients have been helped the most, what the side effects have been, whether there have been any surgical complications and so on. These findings should have been compared to what is known about conventional gastric bypass surgery. 

Criteria

Does the story adequately discuss the costs of the intervention?

Not Satisfactory

The segment failed to disclose the cost (or expected cost) of the procedure.

Does the story adequately quantify the benefits of the treatment/test/product/procedure?

Not Satisfactory

The segment does nothing to report results, other than to say that on average patients in the trials lost nearly 40 percent of their body weight.

Does the story adequately explain/quantify the harms of the intervention?

Not Satisfactory

The story fails to report possible harms of the treatment. While it enumerates the ways in which harms are less likely to occur with the non-surgical method, it says nothing about the harms that pertain to both. These include weight regain as patients find ways to consume high amounts of calories anyway, and nutritional deficiencies.

Does the story seem to grasp the quality of the evidence?

Not Satisfactory

The segment fails to report any evidence from the ongoing trials. The only figure cited is that patients can lose up to 40 percent of their body weight. The segment fails to say, as the press release does, that weight loss in this group has been less than in those who have conventional bypass surgery.

Does the story commit disease-mongering?

Satisfactory

The story does nothing to exaggerate the dangers of morbid obesity.

Does the story use independent sources and identify conflicts of interest?

Not Satisfactory

The segment quotes the one patient who has had the procedure, and one of the physicians treating her.

The reporter should have talked to an independent source.

The fact that the patent-holder on the procedure funded the trials should have been disclosed. 

Does the story compare the new approach with existing alternatives?

Satisfactory

The segment correctly says the main option for obesity of over 100 excess pounds is conventional bypass surgery.

Other interventions for weight loss that are sometimes successful for other populations, such as diet and exercisse, have not been shown effective for the morbidly obese. 

Does the story establish the availability of the treatment/test/product/procedure?

Satisfactory

The story is very clear that this procedure has been performed only twice in the U.S., and has been tested on over 40 people overseas. It says the procedure is not approved for use in the U.S.  

Does the story establish the true novelty of the approach?

Satisfactory

The segment properly reports that the procedure has been done on only two people in the U.S. and around 40 people abroad.

Does the story appear to rely solely or largely on a news release?

Not Applicable

We can’t be sure about the extent to which the story relied on the press release.  We do know that the story uses the same patient that is named in the news release.  We also know that no independent expert source was interviewed. 

Total Score: 4 of 9 Satisfactory

Comments

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.